Obesity and ovarian insufficiency

Cover Page


Cite item

Full Text

Abstract

The article presents resent date of the pathogenesis and treatment of ovarian insufficiency in obese women and overweight and features and complications of pregnancy and delivery in obese women.

About the authors

Elena V Misharina

FSBSI “The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott”

Author for correspondence.
Email: mishellena@gmail.com
PhD, senior researcher at the Department of Endocrinology Russian Federation

Elena I Abashova

FSBSI “The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott”

Email: abashova@yandex.ru
PhD, senior researcher at the Department of Endocrinology Russian Federation

Vladimir V Potin

FSBSI “The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott”

Email: mishellena@gmail.com
MD, PhD, Honoured figure, professor, Head of Department of Endocrinology Russian Federation

References

  1. Информационный бюллетень ВОЗ № 311, январь 2015. [Informacionnyj bjulleten’ VOZ № 311, janvar’ 2015. (In Russ.)]
  2. Schokker DF, Visscher TL, Nooyens AC, et al. Prevalence of overweight and obesity in the Netherlands. Obes Rev. 2007;8:101-8. doi: 10.1111/j.1467-789X.2006.00273.x.
  3. Дедов И.И., Мельниченко Г.А. (ред.). Синдром поликистозных яичников. — М.: МИА, 2006. [Dedov II, Mel’nichenko GA. (ed.). Sindrom polikistoznyh jaich¬nikov. Moscow: MIA; 2006. (In Russ.)]
  4. Мишарина Е.В., Боровик Н.В., и др. Ожирение и репродуктивная система женщины: пособие для врачей / ред. Э.К. Айламазян. — СПб., 2010. [Misharina EV, Borovik NV, Potin VV, et al. Ozhirenie i reproduktivnaja sistema zhenshhiny: posobie dlja vrachej. Ed by Je.K. Ajlamazjan. Saint Petersburg; 2010. (In Russ.)]
  5. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012;307(5):491-7. doi: 10.1001/jama.2012.39.
  6. Fryar CD, Carroll MD, Ogden CL. Prevalence of overweight, obesity, and extreme obesity among adults: United States, 1960-1962 through 2011-2012, sept. 2014. National Center for Health Statistics.
  7. Подзолкова Н.М., Колода Ю.А., Подзолков А.В. Терапия бесплодия у пациенток с ожирением: современный взгляд на проблему // Проблемы репродукции. — 2012. — № 3. — С. 37–41. [Podzolkova NM, Koloda JuA, Podzolkov AV. INFertility Therapy in obese patients: modern trends. Problemy reprodukcii. 2012;3:37-41. (In Russ.)]
  8. Dağ ZÖ, Dilbaz B. Impact of obesity on infertility in women. J Turk Ger Gynecol Assoc. 2015;16(2):111-7. doi: 10.5152/jtgga.2015.15232.
  9. Bates GW. Body weight and reproductive function. Clin Obstet Gynec. 1985;28(3):363-9. doi: 10.1097/00003081-198528030-00012.
  10. Kopelman PG, Caterson ID, Dietz WH, eds. Clinical Оbesity in Adults and Children. Carlton: Blackwell Publishing; 2005.
  11. Khaskheli MN, Baloch S, Baloch AS. Infertility and Weight Reduction: influence and outcome. J College Physicians Surgeons Pakistan. 2013;23(11):798-801.
  12. Беляков Н.А., Сеидова Г.Б., Чубриева С.Ю., Глухов Н.В. Метаболический синдром у женщин. — СПб., 2005. [Beljakov NA, Seidova GB, Chubrieva SJu, Gluhov NV. Metabolicheskij sindrom u zhenshhin. Saint Petersburg; 2005. (In Russ.)]
  13. Frich RE. Pubertal adipose tissue: it is necessary for normal sexual maturation. Evidence from the rat and human femel. FED Proc. 1980;39:2395-2400.14.Frish RE. Fatness and fertility. Scientific American. 1988;258:70-7. doi: 10.1038/scientificamerican0388-88.
  14. Pasquali R, Patton L, Gambinery A. Obesity and inferti¬lity. Curr Opin Endocrinol Diabetes Obes. 2007;14:482-7. doi: 10.1097/MED.0b013e3282f1d6cb.
  15. Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG. 2006;113(10):1148-59. doi: 10.1111/j.1471-0528.2006.00990.x.
  16. Puder JJ, Varga S, Kraenzlin M, et al. Central fat excess in polycystic syndrome: relation to low-grade inflammation and insulin resistance. J Clin Endocrinol Metab. 2005;90:6014-21. doi: 10.1210/jc.2005-1002.
  17. Yildirim B, Sabir N, Kaleli B. Relation of intra-abdominal fat distribution to metabolic desorders in nonobese patients with polycystic ovary syndrome. Fertil Steril. 2003;79:1358-64. doi: 10.1016/S0015-0282(03)00265-6.
  18. Guo Z, Hensrud DD, Johnson CM, Jensen MD. Regional postprandial fatty acid metabolism in different obesity phenotypes. Diabetes. 1999;48:1586-92. doi: 10.2337/diabetes.48.8.1586.
  19. Lebovitz HE, Banerjy MA. Point: visceral adiposity in causally related to insulin resistance. Diabetes Care. 2005;28:2322-25. doi: 10.2337/diacare.28.9.2322.
  20. Bates GW, Whiteworth NS. Effect of body weight reduction on plasma androgens in obese, infertile women. Fertil Steril. 2009;38:406-15. doi: 10.1016/S0015-0282(16)46571-4.
  21. Савина В.А. Овариальная ароматаза р450 при нормогонадотропной недостаточности яичников // Журнал акушерства и женских болезней. — 2012. — Т. LXI. — Вып. 1. — С. 84–89. [Savina VA. Ovarian aromatase р450 and normo gonadotropic ovarian deficiency. Journal of Obstetrics and Women´s Diseases. 2012;61(1):84-9. (In Russ.)]
  22. Денисова В.М., Потин В.В., Ярмолинская М.И., Тимофеева Е.М. Активность овариальной ароматазы при эндометриозе // Журнал акушерства и женских болезней. — 2013. — LXII. Вып. 2. — С. 17–22. [Denisova VM, Potin VV, Jarmolinskaja MI, Timofeeva EM. Ovarian aromatase activity in endometriosis. Journal of Obstetrics and Women´s Diseases. 2013;62(2):17-22. (In Russ.)]
  23. Тимофеева Е.М., Потин В.В., Ярмолинская М.И. Методика определения активности ароматазы // Вестник ВМА. — 2014. — Т. 46. — № 2. — С. 12–21. [Timofeeva EM, Potin VV, Jarmolinskaja MI. The method of determination of ovarion aromatase activity in women of reproductiv age. Vestnik VMA. 2014; 2(46):12-21. (In Russ.)]
  24. Николаенков И.П., Потин В.В., Тарасова М.А., и др. Активность овариальной ароматазы у больных с синдромом поликистозных яичников // Журнал акушерства и женских болезней. — 2014. — Т. LXIII. — Вып. 1. — C. 10–15. [Nikolaenkov IP, Potin VV, Tarasova MA, et al. Ovarian aromatase activity in polycystic ovarian. Journal of Obstetrics and Women´s Diseases. 2014;63(1):10-5. (In Russ.)]
  25. Lebrethon MC, Aganina A, Fournier M, et al. Effects of in vivo and in vitro administration of grelin, leptin and neuropeptide mediators on pulsate gonadotropin-releasing hormone secretion from male rat hypothalamus before and after puberty. J Neuroendocrinol. 2007;19(3):181-8. doi: 10.1111/j.1365-2826.2006.01518.x.
  26. Li M, Song J, Chen SL. Association of the clinical characteristics and the IVF-ET outcome in infertile women with polycystic syndrome of different subtypes. Nan Fang Yi Ke Da Xue Bao. 2009;29(2):224-7.
  27. Rehman R, Teriq S, Usmani A, et al. Interplay of leptin with obesity and polycystic ovarian syndrome. Life Sci J. 2015;12(4):83-9. doi: 10.7537/marslsj120415.10.
  28. Rehana R, Zahir H, Syeda S. Effect of weight status on pregnancy outcome in intra cytoplasmic sperm injection. Iran J Reprod Med. 2013;11(9):717-24.
  29. Мишарина Е.В., Потин В.В., Соболева Е.Л., Мещерякова В.В. Эффективность ингибитора липазы ксеникала в терапии яичниковой недостаточности, обусловленной избыточной массой тела // Новые горизонты эндокринологии: сборник тезисов. — М., 2002. — C. 49. [Misharina EV, Potin VV, Soboleva EL, Meshherjakova VV. Jeffektivnost’ ingibitora lipazy ksenikala v terapii jaichnikovoj nedostatochnosti, obuslovlennoj izbytochnoj massoj tela. In.: Novye gorizonty jendokrinologii: sbornik tezisov. Moscow; 2002. P. 49. (In Russ.)]
  30. Мишарина Е.В., Потин В.В., Боровик Н.В., Тиселько А.В. Лечение недостаточности яичников у больных с ожирением // Signatura. — 2007. — № 2. — C. 46–51. [Misharina EV, Potin VV, Borovik NV, Tisel’ko AV. Lechenie nedostatochnosti jaichnikov u bol’nyh s ozhireniem. Signatura. 2007;2:46-51. (In Russ.)]
  31. Duggal PS, Van der Hoek KH, Milner CR, et al. The in vivo and in vitro effects of exogenous leptin on ovulation in the rat. Endocrinology. 2000;141:1971-6. doi: 10.1210/endo.141.6.7509.
  32. Li XJ, Yu YX, Liu CQ, et al. Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis. Clin Endocrinol. 2011;74(3):332-9. doi: 10.1111/j.1365-2265.2010.03917.x.
  33. Nieuwenhuis-Ruifrok AE, Kuchenbecker WK, Hoek A, et al. Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis. Hum Reprod Update. 2009;15(1):57-68. doi: 10.1093/humupd/dmn043.
  34. Goodman NF, Cobin RH, Futterweit W, et al.; American Association of Clinical Endocrinologists (AACE); American College of Endocrinology (ACE); Androgen Excess and PCOS Society (AES). American association of clinical endocrinologists, American college of endocrinology, and androgen excess and PCOS society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome. Part 1. Endocr Pract. 2015;21(11):1291-300. doi: 10.4158/EP15748.DSC.
  35. Liao L, Tian YJ, Zhao JJ, et al. Metformin versus metformin plus rosiglitazone in women with polycystic ovary syndrome. Clin Med J. 2011;124(5):714-8.
  36. Prerna Upadhyaya, Rehan HS, Seth Vicas. Serum changes with metformin treatment in polycystic ovarian syndrome: correlation with ovulation, insulin and testosterone levels. EXCLI J. 2011;10:9-15.
  37. Van der Steeg JW, Steures P, Eijkemans MJC, et al. Obesity affects spontaneous pregnancy chances in subfertile ovulatory women. Hum Reprod. 2007;23:324-328. doi: 10.1093/humrep/dem371.
  38. Koning AM, Mutsaekmans FJ, Kuchenbecker WK, et al. Complications and outcome of assisted reproduction technologies in overweight and obese women. Hum Reprod. 2012;27(2):457-67. doi: 10.1093/humrep/der416.
  39. Farquhar C, Gillett W. Prioritising for fertility treatments — should a high BMI exclude treatment? BJOG. 2006;113:1107-1109. doi: 10.1111/j.1471-0528.2006.00994.x.
  40. Bellver J, Melo MAB, Bosch E, et al. Obesity and poor reproductive outcome: the potential role of the endometrium. Fertil Steril. 2007;88:446-451. doi: 10.1016/j.fertnstert.2006.11.162.
  41. Bellver J, Ayllon Y, Ferrando M, et al. Female obesity impairs in vitro fertilization outcome without affecting embryo quality. Fertil Steril. 2010;93:447-454. doi: 10.1016/j.fertnstert.2008.12.032.
  42. Hill MJ, Hong S, Frattarelli JL. Body mass index impacts in vitro fertilization stimulation. ISRN Obstet Gynecol. 2011:929-251. doi: 10.5402/2011/929251.
  43. Valckx SD, Arias-Alvarez M, De Pauw I, et al. Fatty acid composition of the follicular fluid of normal weight, overweight and obese women undergoing assisted reproductive treatment: a descriptive cross-sectional study. Reprod Biol Endocrinol. 2014 Feb 5;12:13. doi: 10.1186/1477-7827-12-13.
  44. Esinler I, Bozdag G, Yarali H. Impact of isolated obesity on ICSI outcome. Reprod Biomed Online. 2008;17:583-7. doi: 10.1016/S1472-6483(10)60249-0.
  45. Rehana R, Zahir H, Syeda S. Effect of weight status on pregnancy outcome in intra cytoplasmic sperm injection. Iran J Reprod Med. 2013;11(9):717-24.
  46. Luke B, Brown MB, Stern JE, et al. Female obesity adversely affects assisted reproductive technology (ART) pregnancy and live birth rates. Hum Reprod. 2011;26(1):245-52. doi: 10.1093/humrep/deq306.
  47. Rittenberg V, Seshardi S, Suncara SK, et al. Effect of body mass index on IVF treatment outcome: an updated systematic review and meta-analysis. Reprod Bomed Online. 2011;23(4):421-439. doi: 10.1016/j.rbmo.2011.06.018.
  48. Boots C, Stephenson MD. Does obesity increase the risk of miscarriage in spontaneous conception: a systematic review. Semin Reprod Med. 2011;29:507-13. doi: 10.1055/s-0031-1293204.
  49. Sathya A, Balasubramanyam S, Gupta S, Verma T. Effect of body mass index on in vitro fertilization outcomes in women. J Hum Reprod Sci. 2010;3:135-8. doi: 10.4103/0974-1208.74155.
  50. Metwally M, Saravelos SH, Ledger WL, Li TC. Body mass index and risk of miscarriage in women with recurrent miscarriage. Fertil Steril. 2010;94:290-5. doi: 10.1016/j.fertnstert.2009.03.021.
  51. Metwally M, Preece R, Thomas J, Ledger W. A proteomic analysis of the endometrium in obese and overweight women with recurrent miscarriage: preliminary evidence for an endometrial defect. Repr Biology and Endocrinology. 2014;12:75. doi: 10.1186/1477-7827-12-75.
  52. Weight gain during pregnancy. Committee Opinion No 548. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2013;121:210-2. doi: 10.1097/01.AOG.0000425668.87506.4c.
  53. Sebire NJ, Jolly M, Harris JP, Wadworth J, et al. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord. 2001;25:1175-82. doi: 10.1038/sj.ijo.0801670.
  54. Weiss JL, Malone FD, Emig D, et al. Obesity, obstetric complications and cesarian delivery rate — a population-based screening study. FASTER Research Consortium. Am J Obstet Gynecol. 2004;190:1091-7. doi: 10.1016/j.ajog.2003.09.058.
  55. Vesco KK, Dietz PM, Rizzo J, et al. Excessive gestational weight gain and postpartum weight retention among obese women. Obstet Gynecol. 2009;11:1069-75. doi: 10.1097/AOG.0b013e3181baeacf.
  56. Stothard KJ, Tennant PW, Bell R, Rankin J. Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. JAMA. 2009;301:636-50. doi: 10.1001/jama.2009.113.
  57. Oken T, Taveras EM, Kleiman KP, et al. Gestational weight gain and child adiposity at age 3 years. Am J Obstet Gynecol. 2007;196:322.el-8. doi: 10.1016/j.ajog.2006.11.027.
  58. Obesity in pregnancy. Committee Opinion No. 549. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2013;121:213-7. doi: 10.1097/01.AOG.0000425667.10377.60.
  59. Baeten JM, Bukusi EA, Lambe M. Pregnancy complications and outcomes overweight and obese nulliparous women. Am J Public Health. 2001; 91:436-40. doi: 10.2105/AJPH.91.3.436.
  60. Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol. 2004; 103:219-24. doi: 10.1097/01.AOG.0000107291.46159.00.
  61. Crane JM, Murphy P, Burrage L, Hutchene D. Maternal and perinatal outcomes of extreme obesity in pregnance. J Obstet Gynecol Can. 2013; 35(7):606-11. doi: 10.1016/S1701-2163(15)30879-3.
  62. Alanis MC, Goodnight WH, Hill EQ, et al. Maternal super-obesity (body mass index more or=50) and adverse pregnancy outcomes. Acta Obstet Gynecol Scand. 2010;89(7):924-30. doi: 10.3109/00016341003657884.
  63. Mhyre JM. Anesthetic management for morbidly obese pregnant woman. Int Anesthesiol Clin. 2007; 45:51-70. doi:0.1097/AIA.0b013e31802b8a90.
  64. Karibu W, Raynor BD. Obstetric outcomes associated with increase in BMI category during pregnancy. Am J Obset Gynecol. 2004;191:928-32. doi: 10.1016/j.ajog.2004.06.051.
  65. Myles TD, Gooch J, Santolaya J. Obesity as an independent risk factor for infectious morbidity in patients who undergo cesarean delivery. Obstet Gynecol. 2002;100:959-964. doi: 10.1097/00006250-200211000-00024.
  66. Use of prophylaxis for cesarean delivery; timing of administration. Committee Opinion No. 465. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2011;117:1472-83.
  67. Chelmow D, Rodriguez EJ, Sabatini MM. Suture closure of subcutaneous fat and wound disruption after cesarean delivery: a meta-analysis. Obstet Gynecol. 2004;103:974-80. doi: 10.1097/01.AOG.0000124807.76451.47.
  68. James A. Committee on Practice Bulletins — Obstetrics. Practice bulletin no. 123: thromboembolism in pregnancy. Obstet Gynecol. 2011;118(3):718-29. doi: 10.1097/AOG.0b013e3182310c4c.
  69. Hague WM, North RA, Gallus AS, et al. Anticoagulation in pregnancy and the puerperium. Working Group of the Obstetric Medicine Group of Australasia. Med J Aust. 2001;175:258-63.
  70. Thanqarantinam S, Roqozinska E, Jolly K, et al. Interventions to reduce or prevent obesity in pregnant women: a systematic review. Health Technol Assess. 2012 Jul;16(31):1-191.
  71. Thangaratinam S, Rogozińska E, Jolly K, et al. Interventions to reduce or prevent obesity in pregnant women: a systematic review. Health Technol Assess. 2012;16(31): III-IV, 1-191. doi: 10.3310/hta16310.
  72. Muktabhant B, Lawrie TA, Lumbiganon P, Laopaiboon M. Diet or exercise, or both, for preventing excessive weight gain in pregnancy. Cochrane Database Syst Rev. 2015;(6): CD007145. doi: 10.1002/14651858.
  73. Patel JA, Patel NA, Thomas RL, et al. Pregnancy outcomes after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2008;4:39-45. doi: 10.1016/j.soard.2007.10.008.
  74. Patel JA, Patel NA, Thomas RL, et al. Pregnancy outcomes after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2008;4(1):39-45. doi: 10.1016/j.soard.2007.10.008.
  75. Sheiner E, Levy A, Silverberg D, et al. Pregnancy after bariatric surgery is not associated with adverse perinatal outcome. Am J Obstet Gynecol. 2004;190(5):1335-40. doi: 10.1016/j.ajog.2003.11.004.
  76. Wills K, Sheiner E. Bariatric surgery and pregnancy: the magical solution? J Perinat Med. 2013 Mar; 41(2):133-40. doi: 10.1515/jpm-2012-0237.
  77. Willis K, Lieberman N, Sheiner E. Pregnancy and neonatal outcome after bariatric surgery. Best Pract Res Clin Obstet Gynaecol. 2015;29(1):133-44. doi: 10.1016/j.bpobgyn.2014.04.015.
  78. Johansson K, Cnattingius S, Näslund I, et al. Outcomes of pregnancy after bariatric surgery. N Engl J Med. 2015;372(9):814-24. doi: 10.1056/NEJMoa1405789.
  79. Roos NM, Cnattinqius S, Trolle Laqerros Y, et al. Perinatal outcomes after bariatric surgery: nationwide population based matched cohort study. BMJ. 2013;347: f6460. doi: 10.1136/bmj.f6460.
  80. Koning KV, Kuchenbecker WK, Groen H, et al. Economic consequences of overweight and obesity in infertility: a framework for evaluating the costs and outcomes of fertility care. Hum Reprod Update. 2010 May-Jun;16(3):246-54. doi: 10.1093/humupd/dmp053.
  81. Cedergen MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol. 2004;103:219-224. doi: 10.1097/01.AOG.0000107291.46159.00.
  82. Per Ovesen, Rasmussen S, Kesmodel U. Effect of pregnancy Maternal Overweight and Obesity on pregnancy outcome. Obset Gynecol. 2011;118:305-12. doi.: 10.1097/AOG.0b013e3182245d49.
  83. Ovesen P, Rasmussen S, Kesmodel U. Effect of prepregnancy maternal overweight and obesity on pregnancy outcome. Obstet Gynecol. 2011 Aug;118(2 Pt 1):305-12. doi: 10.1097/AOG.0b013e3182245d49.

Copyright (c) 2016 Misharina E.V., Abashova E.I., Potin V.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies